Moshe Giladi Novo Cure LTD (NVCR) insider trading activity

NVCR Quotes by TradingView

Moshe Giladi is Chief Science Officer of NovoCure Ltd. Currently has a direct ownership of 69,771 shares of NVCR, which is worth approximately $2.14 Million. The most recent transaction as insider was on Feb 27, 2024, when has been sold 51,124 shares (Ordinary Shares) at a price of $16.3 per share, resulting in proceeds of $833,321. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 69.8K
0% 3M change
n/a 12M change
Total Value Held $2.14 Million

Moshe Giladi Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 27 2024
BUY
Grant, award, or other acquisition
$833,321 $16.3 p/Share
51,124 Added 42.29%
69,771 Ordinary Shares
MG

Moshe Giladi

Chief Science Officer
Wayne, PA

Track Institutional and Insider Activities on NVCR

Follow NovoCure Ltd and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NVCR shares.

Notify only if

Insider Trading

Get notified when an Novo Cure LTD insider buys or sells NVCR shares.

Notify only if

News

Receive news related to NovoCure Ltd

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NVCR